ATHIRA PHARMA INC (ATHA) Stock Earnings Estimates
NASDAQ:ATHA • US04746L2034
6.75 USD
-0.44 (-6.12%)
At close: Jan 9, 2026
6.9496 USD
+0.2 (+2.96%)
After Hours: 1/9/2026, 8:00:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -63.54M -98.44% | -93.17M -46.63% | -126.125M -35.37% | -95.805M 24.04% | N/A 26.17% | N/A -4.84% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.01M | -5.45M -8.78% | -20M -266.97% | -64.02M -220.10% | -94.02M -46.86% | -127.094M -35.18% | -96.775M 23.86% | N/A 71.96% | N/A 183.46% | N/A 0.90% | N/A -386.16% | N/A -30.42% | N/A -26.91% | N/A 44.39% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -15.00 11.76% | -22.70 -51.33% | -30.90 -36.12% | -25.30 18.12% | N/A 73.83% | N/A 25.42% | N/A 95.87% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.87 77.64% | -0.19 91.57% | -0.06 96.60% | -0.05 96.96% | -0.05 94.15% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.958M 81.00% | -7.854M 17.64% | -7.854M -7.72% | -7.854M -14.26% | -7.854M -165.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.68 77.60% | -1.24 | -0.44 | -35.00% |
| Q2 2025 Q2Q % growth | -1.80 74.29% | -1.84 | 0.04 | 1.96% |
| Q1 2025 Q2Q % growth | -2.30 66.67% | -2.45 | 0.15 | 6.05% |
| Q4 2024 Q2Q % growth | -3.90 45.07% | -4.49 | 0.59 | 13.23% |
| Q3 2024 Q2Q % growth | -7.50 13.79% | -7.20 | -0.30 | -4.12% |
| Q2 2024 Q2Q % growth | -7.00 10.26% | -7.52 | 0.52 | 6.86% |
| Q1 2024 Q2Q % growth | -6.90 5.48% | -8.06 | 1.16 | 14.42% |
| Q4 2023 Q2Q % growth | -7.10 -33.96% | -9.79 | 2.69 | 27.47% |
| Q3 2023 Q2Q % growth | -8.70 -64.15% | -8.30 | -0.40 | -4.78% |
| Q2 2023 Q2Q % growth | -7.80 -20.00% | -7.99 | 0.19 | 2.36% |
| Q1 2023 Q2Q % growth | -7.30 -30.36% | -6.36 | -0.94 | -14.69% |
| Q4 2022 Q2Q % growth | -5.30 -17.78% | -6.83 | 1.53 | 22.45% |
| Q3 2022 Q2Q % growth | -5.30 -26.19% | -6.46 | 1.16 | 17.96% |
| Q2 2022 Q2Q % growth | -6.50 -71.05% | -6.51 | 0.01 | 0.17% |
| Q1 2022 Q2Q % growth | -5.60 -124.00% | -5.61 | 0.01 | 0.18% |
| Q4 2021 Q2Q % growth | -4.50 -87.50% | -5.51 | 1.01 | 18.30% |
| Q3 2021 Q2Q % growth | -4.20 62.50% | -5.07 | 0.87 | 17.09% |
| Q2 2021 Q2Q % growth | -3.80 | -3.52 | -0.28 | -7.99% |
| Q1 2021 Q2Q % growth | -2.50 | -3.09 | 0.59 | 18.98% |
| Q4 2020 Q2Q % growth | -2.40 | -4.05 | 1.65 | 40.68% |
| Q3 2020 Q2Q % growth | -11.20 | -2.55 | -8.65 | -339.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2020 Q2Q % growth | 68.003K | -68.003K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 15.76% | 15.76% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |